Accelerated Fractionation Radiotherapy and Chemotherapy Might Improve Loco-Regional Control of Head and Neck Squamous Cell Carcinoma

NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED HEAD AND NECK CANCERS

Optimizing a Convenient Protocol in Induction Treatment Of Locally Advanced Head And Neck Cancers: Taxotere- Cisplatin- 5 Fluorouracil versus Cisplatin-5 Fluorouracil

Induction chemotherapy followed by chemoradiation versus upfront chemoradiation in locally advanced head and neck cancers A prospective randomized study

Weekly cisplatin (40 mg/m2) versus three-weekly (100mg/m2) cisplatin delivered concurrently with radiotherapy in high risk head and neck cancer patients

Induction Chemotherapy Versus Upfront Chemoradiation for Locoregionally Advanced of Head and Neck Cancer

CONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN

Approaches combining chemotherapy and radiation therapy in locally advanced head and neck cancers: Retrospective record based study

Treatment Results of Capecitabine Metronomic Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma after Standard Chemoradiotherapy– A Single- Arm Phase II Study

Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience